The In Vitro Replication Cycle of Achromobacter xylosoxidans and Identification of Virulence Genes Associated with Cytotoxicity in Macrophages

An 18-Year Dataset on the Clinical Incidence and MICs to Antibiotics of Achromobacter spp. (Labeled Biochemically or by MAL-DI-TOF MS as A. xylosoxidans), Largely in Patient Groups Other than Those with CF

(2022) Claudio Neidhöfer et al.   Antibiotics-Basel

Transmission and antibiotic resistance of Achromobacter in cystic fibrosis

(2021) Migle Gabrielaite et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Bacterial Re-Colonization Occurs Early after Lung Transplantation in Cystic Fibrosis Patients

(2021) Anna Engell Holm et al.   Journal of Clinical Medicine

Genomic and Phenotypic Evolution of Achromobacter xylosoxidans during Chronic Airway Infections of Patients with Cystic Fibrosis

(2021) S. M. Hossein Khademi et al.   mSystems

Adaptive Interactions of Achromobacter spp. with Pseudomonas aeruginosa in Cystic Fibrosis Chronic Lung Co-Infection

(2021) Angela Sandri et al.   Pathogens

Role of RND Efflux Pumps in Drug Resistance of Cystic Fibrosis Pathogens

(2021) Viola Camilla Scoffone et al.   Antibiotics-Basel

Hypermutation as an Evolutionary Mechanism for Achromobacter xylosoxidans in Cystic Fibrosis Lung Infection

(2020) Laura Veschetti et al.   Pathogens

Achromobacter xylosoxidans cellular pathology is correlated with activation of a type III secretion system

(2020) Adam M. Pickrum et al.   INFECTION AND IMMUNITY

LONGITUDINAL SURVEILLANCE AND COMBINATION ANTIMICROBIAL SUSCEPTIBILITY TESTING OF MULTIDRUG-RESISTANT ACHROMOBACTER SPP. FROM CYSTIC FIBROSIS PATIENTS

(2020) Ijeoma N. Okoliegbe et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High Occurrence of Bacterial Competition Among Clinically Documented Opportunistic Pathogens Including Achromobacter xylosoxidans in Cystic Fibrosis

(2020) Quentin Menetrey et al.   Frontiers in Microbiology

Community-led, integrated, reproducible multi-omics with anvi’o

(2020) A. Murat Eren et al.   Nature Microbiology

A putative enoyl-CoA hydratase contributes to biofilm formation and the antibiotic tolerance of Achromobacter xylosoxidans

(2019) Lydia C. Cameron et al.   npj Biofilms and Microbiomes

Effect of respiratory Achromobacter spp. infection on pulmonary function in patients with cystic fibrosis

(2018) R. Recio et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Linking pangenomes and metagenomes: the Prochlorococcus metapangenome

(2018) Tom O. Delmont et al.   PeerJ

A Pan-Genomic Approach to Understand the Basis of Host Adaptation in Achromobacter

(2017) Julie Jeukens et al.   Genome Biology and Evolution

Structure of a 1.5-MDa adhesin that binds its Antarctic bacterium to diatoms and ice

(2017) Shuaiqi Guo et al.   Science Advances

Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis

(2016) M.C. Firmida et al.   BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH

Patterns of virulence factor expression and antimicrobial resistance in Achromobacter xylosoxidans and Achromobacter ruhlandii isolates from patients with cystic fibrosis

(2016) R. H. V. PEREIRA et al.   EPIDEMIOLOGY AND INFECTION

Thebvg-repressed genebrtA, encoding biofilm-associated surface adhesin, is expressed during host infection byBordetella bronchiseptica

(2016) Sayaka Nishikawa et al.   MICROBIOLOGY AND IMMUNOLOGY

Severe Achromobacter xylosoxidans infection and loss of sputum bacterial diversity in an adult patient with cystic fibrosis

(2016) Nick P. Talbot et al.   Paediatric Respiratory Reviews

Unique lipid anchor attaches Vi antigen capsule to the surface ofSalmonella entericaserovar Typhi

(2016) Sean D. Liston et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Homologs of the LapD-LapG c-di-GMP Effector System Control Biofilm Formation by Bordetella bronchiseptica

(2016) Nicolás Ambrosis et al.   PLoS One

Biotic inactivation of thePseudomonas aeruginosaquinolone signal molecule

(2015) Eliza Ye-Chen Soh et al.   ENVIRONMENTAL MICROBIOLOGY

Intrapatient diversity of Achromobacter spp. involved in chronic colonization of Cystic Fibrosis airways

(2015) Chloé Dupont et al.   INFECTION GENETICS AND EVOLUTION

Stenotrophomonas, Achromobacter, and Nonmelioid Burkholderia Species: Antimicrobial Resistance and Therapeutic Strategies

(2015) Anton Peleg et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

InterProScan 5: genome-scale protein function classification

(2014) P. Jones et al.   BIOINFORMATICS

Structural Features of the Pseudomonas fluorescens Biofilm Adhesin LapA Required for LapG-Dependent Cleavage, Biofilm Formation, and Cell Surface Localization

(2014) C. D. Boyd et al.   JOURNAL OF BACTERIOLOGY

Cyclic Di-GMP-Mediated Repression of Swarming Motility by Pseudomonas aeruginosa PA14 Requires the MotAB Stator

(2014) S. L. Kuchma et al.   JOURNAL OF BACTERIOLOGY

Achromobacter species in cystic fibrosis: Cross-infection caused by indirect patient-to-patient contact

(2013) C.R. Hansen et al.   Journal of Cystic Fibrosis

Complete Genome Sequence of the Cystic Fibrosis Pathogen Achromobacter xylosoxidans NH44784-1996 Complies with Important Pathogenic Phenotypes

(2013) Tim Holm Jakobsen et al.   PLoS One

Innate Aminoglycoside Resistance of Achromobacter xylosoxidans Is Due to AxyXY-OprZ, an RND-Type Multidrug Efflux Pump

(2012) Julien Bador et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

LapG, Required for Modulating Biofilm Formation by Pseudomonas fluorescens Pf0-1, Is a Calcium-Dependent Protease

(2012) C. D. Boyd et al.   JOURNAL OF BACTERIOLOGY

A heat-stable cytotoxic factor produced by Achromobacter xylosoxidans isolated from Brazilian patients with CF is associated with in vitro increased proinflammatory cytokines

(2012) Rebeca P. Mantovani et al.   Journal of Cystic Fibrosis

Identification and distribution of Achromobacter species in cystic fibrosis

(2012) Theodore Spilker et al.   Journal of Cystic Fibrosis

First Description of an RND-Type Multidrug Efflux Pump in Achromobacter xylosoxidans, AxyABM

(2011) Julien Bador et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment

(2011) Winnie Ridderberg et al.   Journal of Cystic Fibrosis

Structural Basis for c-di-GMP-Mediated Inside-Out Signaling Controlling Periplasmic Proteolysis

(2011) Marcos V. A. S. Navarro et al.   PLOS BIOLOGY

A c-di-GMP Effector System Controls Cell Adhesion by Inside-Out Signaling and Surface Protein Cleavage

(2011) Peter D. Newell et al.   PLOS BIOLOGY

Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008

(2010) Julia Emerson et al.   PEDIATRIC PULMONOLOGY

Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients

(2009) C.R. Hansen et al.   Journal of Cystic Fibrosis

Dual Role for Pilus in Adherence to Epithelial Cells and Biofilm Formation in Streptococcus agalactiae

(2009) Yoan Konto-Ghiorghi et al.   PLoS Pathogens